The visit to Incart led by the first lady Raquel Arbaje and the director of the SNS, Dr. Julio César Landrón, took place this Friday in Santo Domingo. The purpose was to evaluate directly the quality of care provided to oncological patients at the National Cancer Institute.
During the visit to Incart, the authorities toured key facilities, including consultation areas, chemotherapy, and radiation therapy. This protocol action seeks to identify strengths and areas for improvement in a vital center for cancer treatment in the Dominican Republic.
Context of the National Cancer Institute
The Incart annually attends thousands of patients with oncological diagnoses. According to data from the Ministry of Public Health, cancer represents one of the main causes of mortality in the country, with over 20,000 new cases reported each year. The visit to Incart responds to the need to optimize resources in a health system under pressure.
Details of the visit to Incart and commitments assumed
Arbaje, known for her interest in social issues, dialogued with medical staff and patients. Landrón emphasized the importance of updated protocols and modern equipment. “We want to guarantee that every Dominican receives the best possible care”, expressed the director of the SNS during the tour.
Background in Dominican oncological health
- The Incart was founded in 1983 as a national reference in oncology.
- In 2023, it received donations of equipment worth millions of dollars from international organizations.
- Experts highlight the gap in early detection, with only 30% of cases identified on time.
This visit to Incart is part of government efforts to strengthen the SNS. Previously, the government announced investments in public hospitals, including expansions in oncology. Opinions of specialists coincide that supervisions like this promote accountability and efficiency.
The initiative highlights the role of the first lady in public health, similar to past visits to other centers. Landrón, at the helm of the SNS for months, has prioritized in-situ evaluations to align services with international standards.
In the Dominican Republic, where breast and prostate cancer lead incidence, actions like the visit to Incart are crucial. Statistics from the WHO indicate that improving care could reduce mortality by 20% in the region.
The visit to Incart by the first lady and the director of the SNS reinforces the focus on oncological patients, promising tangible advances in the short term.
